» Articles » PMID: 11641103

Abolished Tubuloglomerular Feedback and Increased Plasma Renin in Adenosine A1 Receptor-deficient Mice

Overview
Specialty Physiology
Date 2001 Oct 20
PMID 11641103
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

The hypothesis that adenosine acting on adenosine A1 receptors (A1R) regulates several renal functions and mediates tubuloglomerular feedback (TGF) was examined using A1R knockout mice. We anesthetized knockout, wild-type, and heterozygous mice and measured glomerular filtration rate, TGF response using the stop-flow pressure (P(sf)) technique, and plasma renin concentration. The A1R knockout mice had an increased blood pressure compared with wild-type and heterozygote mice. Glomerular filtration rate was similar in all genotypes. Proximal tubular P(sf) was decreased from 36.7 +/- 1.2 to 25.3 +/- 1.6 mmHg in the A1R+/+ mice and from 38.1 +/- 1.0 to 27.4 +/- 1.1 mmHg in A1R+/- mice in response to an increase in tubular flow rate from 0 to 35 nl/min. This response was abolished in the homozygous A1R-/- mice (from 39.1 +/- 4.1 to 39.2 +/- 4.5 mmHg). Plasma renin activity was significantly greater in the A1R knockout mice [74.2 +/- 14.3 milli-Goldblatt units (mGU)/ml] mice compared with the wild-type and A1R+/- mice (36.3 +/- 8.5 and 34.1 +/- 9.6 mGU/ml), respectively. The results demonstrate that adenosine acting on A1R is required for TGF and modulates renin release.

Citing Articles

Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.

Jung I, Nam S, Lee D, Park S, Yu J, Seo J Diabetes Metab J. 2024; 48(6):1126-1134.

PMID: 38945526 PMC: 11621657. DOI: 10.4093/dmj.2023.0377.


Small molecule allosteric modulation of the adenosine A receptor.

Nguyen A, Tran Q, Baltos J, McNeill S, Nguyen D, May L Front Endocrinol (Lausanne). 2023; 14:1184360.

PMID: 37435481 PMC: 10331460. DOI: 10.3389/fendo.2023.1184360.


Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease.

Yang Y, Xu G Front Endocrinol (Lausanne). 2022; 13:872918.

PMID: 35663316 PMC: 9161673. DOI: 10.3389/fendo.2022.872918.


Purinoceptor: a novel target for hypertension.

Li X, Zhu L, Lv J, Cao X Purinergic Signal. 2022; 19(1):185-197.

PMID: 35181831 PMC: 9984596. DOI: 10.1007/s11302-022-09852-8.


Nitric oxide signalling in kidney regulation and cardiometabolic health.

Carlstrom M Nat Rev Nephrol. 2021; 17(9):575-590.

PMID: 34075241 PMC: 8169406. DOI: 10.1038/s41581-021-00429-z.